179 related articles for article (PubMed ID: 10381826)
1. Fluorescent PCR and automated fragment analysis in preimplantation genetic diagnosis for 21-hydroxylase deficiency in congenital adrenal hyperplasia.
Van de Velde H; Sermon K; De Vos A; Lissens W; Joris H; Vandervorst M; Van Steirteghem A; Liebaers I
Mol Hum Reprod; 1999 Jul; 5(7):691-6. PubMed ID: 10381826
[TBL] [Abstract][Full Text] [Related]
2. Identification of non-amplifying CYP21 genes when using PCR-based diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia (CAH) affected pedigrees.
Day DJ; Speiser PW; Schulze E; Bettendorf M; Fitness J; Barany F; White PC
Hum Mol Genet; 1996 Dec; 5(12):2039-48. PubMed ID: 8968761
[TBL] [Abstract][Full Text] [Related]
3. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
4. Congenital adrenal hyperplasia: update on prenatal diagnosis and treatment.
Carlson AD; Obeid JS; Kanellopoulou N; Wilson RC; New MI
J Steroid Biochem Mol Biol; 1999; 69(1-6):19-29. PubMed ID: 10418977
[TBL] [Abstract][Full Text] [Related]
5. Carrier analysis and prenatal diagnosis of congenital adrenal hyperplasia caused by 21-hydroxylase deficiency in Chinese.
Lee HH; Kuo JM; Chao HT; Lee YJ; Chang JG; Tsai CH; Chung BC
J Clin Endocrinol Metab; 2000 Feb; 85(2):597-600. PubMed ID: 10690861
[TBL] [Abstract][Full Text] [Related]
6. CYP21 mutations and congenital adrenal hyperplasia.
Lee HH
Clin Genet; 2001 May; 59(5):293-301. PubMed ID: 11359457
[TBL] [Abstract][Full Text] [Related]
7. Two pregnancies after preimplantation genetic diagnosis for osteogenesis imperfecta type I and type IV.
De Vos A; Sermon K; Van de Velde H; Joris H; Vandervorst M; Lissens W; De Paepe A; Liebaers I; Van Steirteghem A
Hum Genet; 2000 Jun; 106(6):605-13. PubMed ID: 10942108
[TBL] [Abstract][Full Text] [Related]
8. [CYP21 gene point mutations study in 21-hydroxylase deficiency patients].
Liao XY; Zhang YF; Gu XF
Zhonghua Er Ke Za Zhi; 2003 Sep; 41(9):670-4. PubMed ID: 14733808
[TBL] [Abstract][Full Text] [Related]
9. Molecular identification of combined homozygous and compound heterozygous mutations in the CYP21 gene in simple virilizing congenital adrenal hyperplasia in Taiwan.
Wang HH; Lee HH; Wu DA; Lee YJ; Chung BC; Wang TR
Acta Paediatr Taiwan; 2003; 44(6):339-42. PubMed ID: 14983655
[TBL] [Abstract][Full Text] [Related]
10. Direct analysis of CYP21B genes in 21-hydroxylase deficiency using polymerase chain reaction amplification.
Owerbach D; Crawford YM; Draznin MB
Mol Endocrinol; 1990 Jan; 4(1):125-31. PubMed ID: 2325662
[TBL] [Abstract][Full Text] [Related]
11. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia using the polymerase chain reaction.
Owerbach D; Draznin MB; Carpenter RJ; Greenberg F
Hum Genet; 1992 Apr; 89(1):109-10. PubMed ID: 1349559
[TBL] [Abstract][Full Text] [Related]
12. Use of TaqI digestion may lead to incorrect molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Lee HH; de Wijs IJ; Sistermans EA
Mol Genet Metab; 2000 Aug; 70(4):322-4. PubMed ID: 10993720
[TBL] [Abstract][Full Text] [Related]
13. Screening for mutations of 21-hydroxylase gene in Hungarian patients with congenital adrenal hyperplasia.
Ferenczi A; Garami M; Kiss E; Pék M; Sasvári-Székely M; Barta C; Staub M; Sólyom J; Fekete G
J Clin Endocrinol Metab; 1999 Jul; 84(7):2369-72. PubMed ID: 10404805
[TBL] [Abstract][Full Text] [Related]
14. Potential advantage of N363S glucocorticoid receptor polymorphism in 21-hydroxylase deficiency.
Luczay A; Török D; Ferenczi A; Majnik J; Sólyom J; Fekete G
Eur J Endocrinol; 2006 Jun; 154(6):859-64. PubMed ID: 16728546
[TBL] [Abstract][Full Text] [Related]
15. Molecular approaches for the diagnosis of 21-hydroxylase deficiency and congenital adrenal hyperplasia.
Wedell A
Clin Lab Med; 1996 Mar; 16(1):125-37. PubMed ID: 8867587
[TBL] [Abstract][Full Text] [Related]
16. A rapid screening for steroid 21-hydroxylase mutations in patients with congenital adrenal hyperplasia. Mutations in brief no. 247. Online.
Kapelari K; Ghanaati Z; Wollmann H; Ventz M; Ranke MB; Kofler R; Peters H
Hum Mutat; 1999; 13(6):505. PubMed ID: 10408786
[TBL] [Abstract][Full Text] [Related]
17. Allele-dropout using PCR-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a Taq/Pwo-polymerase mixture.
Schulze E; Bettendorf M; Maser-Gluth C; Decker M; Schwabe U
Endocr Res; 1998; 24(3-4):637-41. PubMed ID: 9888552
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of the CYP21 gene and prenatal diagnosis in families with 21-hydroxylase deficiency in northeastern Iran.
Vakili R; Baradaran-Heravi A; Barid-Fatehi B; Gholamin M; Ghaemi N; Abbaszadegan MR
Horm Res; 2005; 63(3):119-24. PubMed ID: 15775714
[TBL] [Abstract][Full Text] [Related]
19. Prenatal diagnosis and treatment of 11beta-hydroxylase deficiency congenital adrenal hyperplasia resulting in normal female genitalia.
Cerame BI; Newfield RS; Pascoe L; Curnow KM; Nimkarn S; Roe TF; New MI; Wilson RC
J Clin Endocrinol Metab; 1999 Sep; 84(9):3129-34. PubMed ID: 10487675
[TBL] [Abstract][Full Text] [Related]
20. Salt-wasting congenital adrenal hyperplasia: detection and characterization of mutations in the steroid 21-hydroxylase gene, CYP21, using the polymerase chain reaction.
Owerbach D; Ballard AL; Draznin MB
J Clin Endocrinol Metab; 1992 Mar; 74(3):553-8. PubMed ID: 1740489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
